Boston Scientific Corporation
Clinical trials sponsored by Boston Scientific Corporation, explained in plain language.
-
New balloon device tested to keep heart arteries open
Disease control OngoingThis study compares two different drug-coated balloon catheters used to open small, narrowed heart arteries in Japanese patients with coronary artery disease. The research aims to see if one device is safer or more effective at keeping the artery open and preventing future heart …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
Heart implant aims to ditch daily blood thinner pills for millions
Disease control OngoingThis study is testing if a small device implanted in the heart (called WATCHMAN FLX) is a safe and effective alternative to taking daily blood-thinning pills for people with atrial fibrillation (AFib). The goal is to prevent strokes without the long-term risk of serious bleeding …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New device tested to break up dangerous lung clots
Disease control OngoingThis study compares two treatments for serious lung blood clots (pulmonary embolism). Researchers want to see if adding a special ultrasound device to standard blood thinners works better than blood thinners alone. The device delivers clot-dissolving medicine directly to the clot…
Phase: PHASE4 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Two-Pronged attack on liver cancer enters clinical testing
Disease control OngoingThis study is testing a two-step treatment for liver cancer. First, doctors deliver tiny radioactive beads directly to the liver tumor. Then, patients receive two immunotherapy drugs designed to help the immune system fight the cancer. The goal is to see if this combination can b…
Phase: PHASE2 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New heart valve tested against established options
Disease control OngoingThis study tested the ACURATE Transfemoral Aortic Valve System, a device to replace a narrowed aortic valve without open-heart surgery. It compared the ACURATE valve against other commercially available replacement valves in nearly 2,000 patients with severe aortic stenosis. The …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Tiny ring offers new hope for failing hearts without surgery
Disease control OngoingThis study is testing a new device called the Millipede Ring for people with a leaky mitral heart valve. The device is placed using a catheter through a vein, avoiding open-heart surgery. The goal is to see if this procedure is safe and works for patients who are too sick for tra…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New gel protects rectum during prostate cancer treatment
Disease control OngoingThis study is testing a new gel called SpaceIT that is placed between the prostate and rectum before radiation therapy for prostate cancer. The goal is to see if this gel safely creates space to protect the rectum from radiation damage, potentially reducing side effects. It is be…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New balloon fights heart stent Re-Clogging
Disease control OngoingThis study is testing whether a special balloon coated with a drug (paclitaxel) works better than a standard balloon to treat arteries that have narrowed again after a previous stent placement. About 600 patients with this condition, called in-stent restenosis, will be randomly a…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Major heart rhythm study tracks new ablation technology in 1,000+ patients
Disease control OngoingThis study is collecting real-world information about how well the FARAPULSE pulsed field ablation system works for treating atrial fibrillation. Researchers are following about 1,173 patients across Europe who receive this treatment as part of their normal hospital care. The goa…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New heart procedure shows promise for controlling irregular heartbeat
Disease control OngoingThis study is tracking the long-term safety and effectiveness of the FARAPULSE pulsed field ablation system, a medical device that treats paroxysmal atrial fibrillation (a type of irregular heartbeat). Researchers are following 228 patients who have undergone this procedure to se…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New heart zapping procedure takes on standard drugs in major AFib trial
Disease control OngoingThis study is testing whether a new, minimally invasive heart procedure called pulsed field ablation (PFA) works better and is safer than standard anti-arrhythmic drugs as the very first treatment for people with persistent atrial fibrillation (AFib). It will involve about 484 ad…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Heart devices 'Talk' to stop deadly rhythms in new trial
Disease control OngoingThis study is testing a new two-part heart device system designed to control dangerous, fast heart rhythms. It involves 297 people who are at risk for these rhythms. The main goals are to see if the two implanted devices can communicate successfully and to check if the system is …
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Spinal Implant's Long-Term relief tracked in major study
Disease control OngoingThis study follows 166 patients for five years to see how well the Superion device works for lumbar spinal stenosis in everyday medical practice. It checks if the device safely reduces leg and buttock pain and improves physical function compared to earlier trial results. The goal…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Radiation beads vs. chemo: Head-to-Head liver cancer battle
Disease control OngoingThis study compares two treatments for liver cancer that cannot be removed by surgery. It tests whether TheraSphere (tiny radioactive glass beads) works better and is safer than the standard chemoembolization treatment. The trial involves 92 Chinese patients and measures how long…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Tiny radioactive beads tested to zap prostate tumors from inside
Disease control OngoingThis early study is testing a new way to treat prostate cancer by delivering tiny radioactive glass beads directly into the tumor's blood supply. The goal is to find the safest and most effective dose of this targeted radiation therapy for men with localized prostate cancer who h…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Massive heart stent study tracks 2,000 patients
Disease control OngoingThis study is monitoring how well SYNERGY heart stents work in real-world medical practice in China. It will follow 2,000 adult patients who receive these stents for heart artery blockages for up to 5 years. The goal is to collect safety and effectiveness data after the stents we…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Steam vs. pills: new battle for prostate relief
Disease control OngoingThis study compares two approaches for men whose enlarged prostate symptoms aren't controlled by their current medication. One group receives a minimally invasive water vapor treatment, while the other gets a combination of two prescription drugs. Researchers will track symptom i…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New balloon aims to stop heart stents from clogging again
Disease control OngoingThis study is testing a special balloon coated with a drug (paclitaxel) to treat arteries that have narrowed again inside an old heart stent, a condition called in-stent restenosis. The balloon is inflated at the narrowed spot to reopen the artery and deliver the drug, which aims…
Phase: PHASE3 • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New device aims to keep Life-Saving dialysis ports working longer
Disease control OngoingThis study is testing a special balloon catheter coated with a drug (paclitaxel) to see if it can keep narrowed dialysis access points (arteriovenous fistulas) open and working better for longer. It involves 186 adults who need regular hemodialysis and have a specific type of nar…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Study for new bile duct tool withdrawn before starting
Disease control TerminatedThis study aimed to test a new medical tool designed to help drain blocked bile ducts in people with cancer. The goal was to see if the device was safe and could reliably create an access point for drainage when other procedures had failed or weren't possible. The study was withd…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Heart device study tests simpler drug regimens to prevent strokes
Disease control OngoingThis study aims to find the safest and most effective medication plan after implanting a device that helps prevent strokes in people with atrial fibrillation. It compares three different drug approaches: aspirin alone, a low-dose blood thinner, or a two-drug combination. The goal…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Zapping a neck nerve to help a failing heart
Disease control OngoingThis study tested whether gently stimulating a nerve in the neck (the vagus nerve) could help improve the heart's structure and function in people with moderate to severe heart failure. It involved 118 participants who had a weakened heart muscle. The goal was to see if this nerv…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
Trial for Single-Use medical scope withdrawn before starting
Diagnosis TerminatedThis study aimed to test a new, disposable duodenoscope for ERCP procedures in China. ERCP is a procedure doctors use to diagnose and treat problems in the bile and pancreatic ducts. The goal was to see if this single-use scope could successfully complete procedures without needi…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Doctors test tiny camera to map hidden pancreas growths
Diagnosis OngoingThis study is testing a tiny camera, called a pancreatoscope, used during surgery for a pancreatic growth called IPMN. The goal is to see if this tool helps surgeons find more hidden growths that standard methods might miss. The results will help plan a larger future study to see…
Sponsor: Boston Scientific Corporation • Aim: Diagnosis
Last updated Mar 03, 2026 14:07 UTC
-
Zapping spinal nerves to ease diabetic pain
Symptom relief OngoingThis study is testing whether spinal cord stimulation can help reduce chronic nerve pain in the limbs of people with diabetes. Researchers are measuring how much pain relief participants experience over 12 months and whether they feel their condition has improved. The study invol…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Mar 31, 2026 12:10 UTC
-
New spinal stimulator aims for quicker pain relief without tingling
Symptom relief OngoingThis study is testing a new type of spinal cord stimulator designed to relieve chronic pain quickly and without the usual tingling sensation. It involves 177 adults with long-term back and limb pain. The main goal is to see how many people get at least 50% pain reduction three mo…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
Gel shield aims to spare men painful bowel damage from prostate cancer treatment
Symptom relief OngoingThis study is testing whether a temporary gel called SpaceOAR Vue can protect the bowel from damage during a precise type of radiation therapy for prostate cancer. The goal is to see if the gel reduces serious bowel side effects like pain, bleeding, or diarrhea that can occur mon…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC
-
New stent offers hope for cancer patients struggling to eat
Symptom relief TerminatedThis study is testing a special stent placed during a scope procedure to help patients with inoperable cancer who have a stomach blockage. The goal is to see if this procedure is safe and can help patients eat more easily by creating a new opening. It involves up to 67 patients a…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Mar 23, 2026 15:24 UTC
-
New stent offers hope for easing Cancer-Related jaundice
Symptom relief TerminatedThis study is testing a specific medical stent to see if it improves quality of life for people with cancer that is blocking their bile ducts. It focuses on patients who need drainage after a standard procedure (ERCP) has already failed. The main goal is to see if placing this st…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Mar 18, 2026 14:41 UTC
-
Doctors map best practices for common heart rhythm procedure
Knowledge-focused OngoingThis study aims to find the best ways for doctors to perform a procedure called pulsed field ablation for atrial fibrillation (AFib). It will observe 524 patients undergoing this standard treatment to see which specific steps and techniques lead to the best safety and long-term r…
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC
-
Registry tracks Long-Term results of penile implants
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry that collects real-world information on the safety and effectiveness of commercially available Boston Scientific penile implants. It will follow 450 adult men who choose to have the implant to treat their erectile dysfunction. The main goal is to monitor …
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Doctors test Next-Gen heart mapping tech during real procedures
Knowledge-focused OngoingThis study is testing new software features for a heart rhythm mapping system. During standard care procedures for irregular heartbeats, data is collected to help improve future versions of the mapping software. The new features being tested do not affect the patient's treatment …
Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC
-
Tiny heart monitors aim to predict hospital visits
Knowledge-focused OngoingThis study aims to collect data from small implanted heart monitors to help design better tools for detecting when heart failure is getting worse. It involves 525 adults with moderate heart failure who agree to have the monitor implanted and use a related phone app. The goal is t…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC